These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE. Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [Abstract] [Full Text] [Related]
11. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. Flynn DD, Mash DC. J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841 [Abstract] [Full Text] [Related]
12. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart. Evans RA, Watson M, Yamamura HI, Roeske WR. J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156 [Abstract] [Full Text] [Related]
13. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study. Tonnaer JA, Ernste BH, Wester J, Kelder K. J Chem Neuroanat; 1988 Dec; 1(2):95-110. PubMed ID: 3267343 [Abstract] [Full Text] [Related]
14. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration. Lee W, Wolfe BB. Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673 [Abstract] [Full Text] [Related]
15. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists. Gillard M, Waelbroeck M, Christophe J. Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611 [Abstract] [Full Text] [Related]
16. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium. Dunlap J, Brown JH. Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150 [Abstract] [Full Text] [Related]
17. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart. Luthin GR, Harkness J, Artymyshyn RP, Wolfe BB. Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425 [Abstract] [Full Text] [Related]
18. Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies. Araujo DM, Lapchak PA, Quirion R. Synapse; 1991 Nov; 9(3):165-76. PubMed ID: 1776129 [Abstract] [Full Text] [Related]
19. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex. Ehlert FJ, Jenden DJ. Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562 [Abstract] [Full Text] [Related]
20. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes. el-Fakahany EE, Ramkumar V, Lai WS. J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473 [Abstract] [Full Text] [Related] Page: [Next] [New Search]